On March 29, 2025, the University of Utah received a revised Notice of Award from the National Center for Advancing Translational Sciences restoring funding to the UM1 grant supporting the...
Since 2019, the University of Utah has been developing the world’s most advanced “neuroprosthesis” — an artificial upper arm and hand that is controlled by the user’s thoughts. Named the...
Health sciences research has more than doubled in size over the past 12 years, a trajectory that highlights U of U Health as a destination for leading faculty, learners, and...
The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.
The therapy increases the amount of blood the heart can pump and dramatically improves survival, in what a paper describing the results calls “an unprecedented recovery of cardiac function.”
Researchers have found that some coronavirus genes don’t produce a working protein, but nevertheless appear to give the viruses an evolutionary leg up. Their work investigating how these mystery genes...
On November 4, NASA crew and ground-based scientists sent blood cells to the International Space Station to learn why astronauts have a higher risk of blood clots.
